The grants have been the source of new treatments for cancer, heart disease, diabetes, strokes and H.I.V.; wonder drugs like ...

U.S. investors and large pharmaceutical companies are increasingly doing deals in China as the country’s biopharma sector ...

When done safely and securely, automated inbound engagement can provide significant benefits for pharmaceutical companies.

Sudair Pharma aims to localise insulin production, contributing to the continuity of supply and reducing reliance on imports ...

The Trump administration's decision to pause enforcement of an anti-bribery law raised the specter that drugmakers could ...

However, P V Appaji, former director general of Pharmexcil finds that the interest of Indian companies to get approvals for ...

With Chinese firms becoming major players in drug development, the traditional balance of power in global pharmaceuticals is ...

Vaccine policy, Medicare drug negotiations, and a potential DTC advertising ban will all fall under Kennedy’s purview as HHS ...

Deborah McElhone, Head of Sustainability (Pharma) from CPI, argues that process intensification is a game changer for the ...

Today, majors across segments including Parle Industries, Easy Trip Planners, Bajaj Consumer Care, Aditya Birla Fashion & ...

Swedish biotech company Gesynta Pharma AB has secured $27 million in a Series B financing round led by Innovestor Life Science in Finland.

“Companies are realizing that investing stateside can provide more control and resilience to the drug supply chain,” says ...